246 related articles for article (PubMed ID: 30958398)
1. Androgens and depression: a review and update.
Nead KT
Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):175-179. PubMed ID: 30958398
[TBL] [Abstract][Full Text] [Related]
2. Androgens and prostate cancer; pathogenesis and deprivation therapy.
Grossmann M; Cheung AS; Zajac JD
Best Pract Res Clin Endocrinol Metab; 2013 Aug; 27(4):603-16. PubMed ID: 24054933
[TBL] [Abstract][Full Text] [Related]
3. Partial androgen deficiency, depression and testosterone treatment in aging men.
Amore M; Scarlatti F; Quarta AL; Tagariello P
Aging Clin Exp Res; 2009 Feb; 21(1):1-8. PubMed ID: 19225262
[TBL] [Abstract][Full Text] [Related]
4. Testosterone Therapy in Men With Prostate Cancer.
Kaplan AL; Hu JC; Morgentaler A; Mulhall JP; Schulman CC; Montorsi F
Eur Urol; 2016 May; 69(5):894-903. PubMed ID: 26719015
[TBL] [Abstract][Full Text] [Related]
5. Should testosterone replacement be offered to hypogonadal men treated previously for prostatic carcinoma?
Landau D; Tsakok T; Aylwin S; Hughes S
Clin Endocrinol (Oxf); 2012 Feb; 76(2):179-81. PubMed ID: 21951017
[TBL] [Abstract][Full Text] [Related]
6. Prevention of prostate cancer by androgens: experimental paradox or clinical reality.
Algarté-Génin M; Cussenot O; Costa P
Eur Urol; 2004 Sep; 46(3):285-94; discussion 294-5. PubMed ID: 15306098
[TBL] [Abstract][Full Text] [Related]
7. Androgen replacement therapy and prostate safety.
Morales A
Eur Urol; 2002 Feb; 41(2):113-20. PubMed ID: 12074396
[TBL] [Abstract][Full Text] [Related]
8. Androgen replacement therapy after prostate cancer treatment.
Khera M
Curr Urol Rep; 2010 Nov; 11(6):393-9. PubMed ID: 20838944
[TBL] [Abstract][Full Text] [Related]
9. Intra-prostatic androgen levels during various androgen-blockade regimens.
Nishiyama T
Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):229-41. PubMed ID: 18471782
[TBL] [Abstract][Full Text] [Related]
10. Adrenocorticotropic hormone is involved in regulation of androgen synthesis in men receiving androgen deprivation therapy for localized prostate cancer.
Takizawa I; Hara N; Nishiyama T; Isahaya E; Hoshii T; Takahashi K
J Urol; 2010 Nov; 184(5):1971-6. PubMed ID: 20884032
[TBL] [Abstract][Full Text] [Related]
11. Researchers probe consequences of androgen deprivation for prostate cancer.
Friedrich MJ
JAMA; 2006 Nov; 296(19):2305-6. PubMed ID: 17105787
[No Abstract] [Full Text] [Related]
12. Re: Testosterone replacement therapy in men with prostate cancer: a time-varying analysis.
Seftel AD
J Urol; 2015 Jun; 193(6):1985-6. PubMed ID: 25986797
[No Abstract] [Full Text] [Related]
13. Effect of topical vaginal androgens in a woman on the testosterone levels of her sexual partner with prostate cancer.
Al-Marrawi MY; Cream LV; Mallon CA; Holder S; Joshi M; Harvey HH; Talamo G; Drabick JJ
J Clin Oncol; 2015 Feb; 33(5):521-2. PubMed ID: 25559812
[No Abstract] [Full Text] [Related]
14. Risk of fracture in men with prostate cancer on androgen deprivation therapy: a population-based cohort study in New Zealand.
Wang A; Obertová Z; Brown C; Karunasinghe N; Bishop K; Ferguson L; Lawrenson R
BMC Cancer; 2015 Nov; 15():837. PubMed ID: 26525985
[TBL] [Abstract][Full Text] [Related]
15. Testosterone replacement therapy in prostate cancer patients: is it safe?
Umbas R; Sugiono M
Acta Med Indones; 2010 Jul; 42(3):171-5. PubMed ID: 20724773
[TBL] [Abstract][Full Text] [Related]
16. Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
Ferreira U; Leitao VA; Denardi F; Matheus WE; Stopiglia RM; Netto NR
Prostate Cancer Prostatic Dis; 2006; 9(1):39-41. PubMed ID: 16276352
[TBL] [Abstract][Full Text] [Related]
17. Use of testosterone replacement therapy in the United States and its effect on subsequent prostate cancer outcomes.
Kaplan AL; Hu JC
Urology; 2013 Aug; 82(2):321-6. PubMed ID: 23706552
[TBL] [Abstract][Full Text] [Related]
18. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
19. Hormonal therapy of prostate cancer.
Labrie F
Prog Brain Res; 2010; 182():321-41. PubMed ID: 20541672
[TBL] [Abstract][Full Text] [Related]
20. Androgen suppression by hydrocortisone without aminoglutethimide in orchiectomised men with prostatic cancer.
Plowman PN; Perry LA; Chard T
Br J Urol; 1987 Mar; 59(3):255-7. PubMed ID: 3567487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
